Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-02-05 | 2020-02-21 | 105352 |
| APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2020-02-05 | 2020-06-02 | 105356 |
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2020-02-05 | 2020-03-11 | 105359 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-02-05 | 2020-03-27 | 105367 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-02-13 | 2020-04-23 | 105988 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-13 | 2020-04-07 | 105991 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2020-02-13 | 2020-04-14 | 105997 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2020-02-13 | 2020-10-13 | 106000 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2020-02-13 | 2020-02-28 | 106003 |
| APO-OLANZAPINE | 5.0MG | TABLET | Resolved | 2020-02-13 | 2020-06-02 | 106006 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2020-02-13 | 2020-06-22 | 106056 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-26 | 2020-04-07 | 107196 |
| APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107693 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107711 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-03-04 | 2020-04-09 | 107714 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2020-03-04 | 2020-04-07 | 107717 |
| ALYSENA 28 | 20MCG 100MCG | TABLET | Resolved | 2020-03-18 | 2020-04-13 | 108920 |
| APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108927 |
| APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108930 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2020-03-18 | 2020-04-09 | 108946 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |